Clinical Trials Directory

Trials / Completed

CompletedNCT05679453

Lornoxicam Versus Etodolac After Third Molar Surgery

Comparison of Lornoxicam and Etodolac on Edema, Trismus and Pain After Third Molar Surgery

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Kutahya Health Sciences University · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

Our study aimed to compare the effect of lornoxicam and etodolac on postoperative pain, edema and trismus following lower third molar extraction

Detailed description

20 patients included in study (4 male, 16 female). Lornoxicam and etodolac was given following lower third molar extraction. Pain was evaluated 2., 6., 12., 24., and 48. hours using VAS. Edema was evaluated by measuring tragus-labial commissure, angulus- lateral canthus of eye and angulus mandible-labial commissure. Trismus was evaluated measuring mouth opening by caliper. Edema and Trismus was evaluated by 48. and 168. hours

Conditions

Interventions

TypeNameDescription
DRUGLornoxicam 8 Mg Oral TabletLornoxicam is a oxicam grup non-steroid antiinflamatuar drug

Timeline

Start date
2022-07-20
Primary completion
2022-09-25
Completion
2022-09-29
First posted
2023-01-11
Last updated
2023-01-11

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05679453. Inclusion in this directory is not an endorsement.

Lornoxicam Versus Etodolac After Third Molar Surgery (NCT05679453) · Clinical Trials Directory